Where does Zyvex Labs, LLC rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Zyvex Labs, LLC ranks #34,017 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Zyvex Labs, LLC hold?

Zyvex Labs, LLC holds 8 US utility patents granted between 2016 and 2022, spanning 13 technology areas.

What is Zyvex Labs, LLC's Innovation Score?

Zyvex Labs, LLC has an Innovation Score of 37.6 out of 100 (top 43% of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

What technology areas does Zyvex Labs, LLC focus on?

Zyvex Labs, LLC's top technology area is A61N (ELECTROTHERAPY; MAGNETOTHERAPY; Radiation THERAPY; Ultrasound Therapy) with 4 patents, ranking #794 of 1,943 assignees active in that subclass. Grants appear in 13 CPC subclasses total.

Is Zyvex Labs, LLC's patent grant rate increasing or decreasing?

Zyvex Labs, LLC's recent grant velocity is -40% compared to the prior five-year period (grant years, not application filing dates). Grant activity has slowed relative to earlier years.

What does claim depth mean for Zyvex Labs, LLC's patents?

Zyvex Labs, LLC's patents average 25.4 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Zyvex Labs, LLC patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView US Corporation

Zyvex Labs, LLC

USPTO PatentsView assignee record - 8 granted patents across 13 technology areas, recorded in grant years 2016–2022. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61N (ELECTROTHERAPY; MAGNETOTHERAPY; Radiation THERAPY; Ultrasound Therapy).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Zyvex ranks #34,017 of 49,997 tracked US assignees by granted-patent volume, with 8 patents across 13 technology areas.

#34,017
of 49,997 US assignees by volume: Top 43%
by Innovation Score (37.6/100): 25.4
avg claims per patent: -40%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R34017 · US Corporation #34,017 · 8 grants

GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-FOCUS · INNOV-THIN · CLAIMS-DENSE · TYPE-USCORP · VEL-DOWN · BOOK-FULL

GRANTS-MICRO 8 grants
MID-PACK #34,017/49,997
PHOTO-FINISH Zappos IP
CPC-FOCUS A61N · 13 areas
INNOV-THIN 37.6/100
CLAIMS-DENSE 25.4 claims/avg
TYPE-USCORP US Corporation
VEL-DOWN -40% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: Zappos IP LLC (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Zyvex’s 37.6 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 7.6 pts (20%) Velocity 2.2 pts (6%) Breadth 12.7 pts (34%) Claim depth 15.0 pts (40%)

Qualcomm Incorporated · highest

85
Zyvex Labs · this assignee

38
3D Lighting… · lowest

7

What this shows Zyvex's Innovation Score is 37.6/100 (top 43% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Zyvex?

Each dot is one of Zyvex’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Zyvex’s own 25.4 claims/patent is ABOVE the 13.6 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.

Zyvex vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Zyvex's grants concentrate

Zyvex Labs, LLC is a focused PatentsView assignee: 13 CPC subclasses with 50% of grants classified under A61N (ELECTROTHERAPY; MAGNETOTHERAPY; Radiation THERAPY; Ultrasound Therapy). Peak complete grant year is 2016 (2 grants) versus a trough of 1 in 2019. By volume, Zyvex sits between Zkteco USA LLC and Zendar Inc..

Zyvex's three-year grant acceleration

Zyvex Labs, LLC shows 1 grants in 2022–2024 against only 3 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Zkteco USA

8
Zoran (France)

8
Zumex Group

8
ZUP

8
Zappos IP

8
Zavation

8
Zebware AB

8
Zendar

8
Zyvex Labs ◀

8

What this shows Zyvex holds 8 patents at rank #33,978, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Zyvex

By rank, the assignees closest to #33,978 in granted patent volume.

Leaders in A61N (Electrotherapy)

Other assignees with the most granted patents in Zyvex's primary technology class.

Zyvex's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

38 Top 43% higher than 57% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2016–2022

Grants by year

Teal-shaded recent years (2020–present) versus the 2016–2019 baseline. Full figures in the table below.

View data table

Zyvex Labs, LLC patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2016	2	25.0%
2018	2	25.0%
2019	1	12.5%
2020	1	12.5%
2021	1	12.5%
2022	1	12.5%

Which technologies does Zyvex Labs, LLC patent most?

A61N - ELECTROTHERAPY; MAGNETOTHERAPY; Radiation THERAPY; Ultrasound Therapy 4

A61B - DIAGNOSIS; SURGERY; Identification 3

G01Q - Scanning-probe Techniques OR APPARATUS; Applications OF Scanning-probe Techniques, e.g. Scanning Probe Microscopy [SPM] 3

Y10T - Technical Subjects Covered BY Former US Classification 2

B82B - Nanostructures Formed BY Manipulation OF Individual Atoms, Molecules, OR Limited Collections OF Atoms OR Molecules AS Discrete UNITS; Manufacture OR Treatment Thereof 2

H01J - Electric Discharge Tubes OR Discharge Lamps 2

C12Q - Measuring OR Testing Processes Involving Enzymes, Nucleic Acids OR Microorganisms ; Compositions OR Test Papers THEREFOR; Processes OF Preparing Such COMPOSITIONS; Condition-responsive Control IN Microbiological OR Enzymological Processes 1

G01N - Investigating OR Analysing Materials BY Determining Their Chemical OR Physical Properties 1

G02B - Optical Elements, Systems OR Apparatus 1

H04B - Transmission 1

H02J - Circuit Arrangements OR Systems FOR Supplying OR Distributing Electric POWER; Systems FOR Storing Electric Energy 1

G05D - Systems FOR Controlling OR Regulating Non-electric Variables 1

G05B - Control OR Regulating Systems IN GENERAL; Functional Elements OF Such SYSTEMS; Monitoring OR Testing Arrangements FOR Such Systems OR Elements 1

Top 13 of 13 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

Zyvex Labs, LLC's patent record in context - here's where to go next.

Zyvex Labs, LLC's lead technology class is A61N (ELECTROTHERAPY; MAGNETOTHERAPY; Radiation THERAPY; Ultrasound Therapy), 50% of its portfolio - see every assignee active in that class. Explore A61N
Ranked #34,017 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Zyvex Labs, LLC against Zkteco USA LLC, an assignee filing at a similar volume. Compare portfolios
Innovation Score of 37.6/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent , US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.